Answer
The pharmacokinetics of glycerol phenylbutyrate have not been studied in patients with impaired renal function, including those with end-stage renal disease or those on haemodialysis.
Sources for this answer
- RAVICTI 1.1 g/ml oral liquidImmedica · emc · SmPC §5.2 Pharmacokinetic properties · Version 7Document updated
Sources checked